603 filings
Page 4 of 31
8-K
29w7q8 wq7w5uk04
31 Mar 22
Protalix BioTherapeutics Reports Fiscal Year 2021 Financial and Business Results
7:01am
8-K
zl2ajdf
24 Feb 22
Other Events
9:19am
8-K
0j9kd9hv
22 Dec 21
Protalix BioTherapeutics Issues 2021 Letter to Stockholders
6:55am
8-K
ndbuc3k
24 Nov 21
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
0xvtx2ek
15 Nov 21
BioTherapeutics Reports Third Quarter 2021 Financial
7:06am
DEFA14A
bxvp7aqcsg1
9 Nov 21
Additional proxy soliciting materials
4:30pm
8-K
gr5 s0u5gzm
12 Oct 21
Protalix Biotherapeutics and Chiesi Global Rare Diseases Provide Regulatory Update on PRX-102 for the Treatment of Fabry Disease
6:03am
8-K
a0yt2qilivmm
26 Aug 21
Protalix BioTherapeutics Announces Closing of Private Note Exchange
7:16am
8-K
dukroc
16 Aug 21
Protalix BioTherapeutics Reports Second Quarter 2021 Financial
7:08am
8-K
lw7c6xz m8
13 Aug 21
Protalix BioTherapeutics Announces Private Note Exchange
7:05am
8-K
3eq0mle11wtgunaj7ki
7 Jul 21
Submission of Matters to a Vote of Security Holders
4:31pm
424B5
wf7opdebj twvh7qf
2 Jul 21
Prospectus supplement for primary offering
5:10pm
8-K
iog770mqt
2 Jul 21
Entry into a Material Definitive Agreement
5:05pm
424B5
066 8q59ye
2 Jul 21
Prospectus supplement for primary offering
5:01pm
8-K
7ni7phqh
30 Jun 21
Other Events
5:23pm